82 related articles for article (PubMed ID: 10448662)
1. Development of a monoclonal antibody to the aP2 protein to identify adipocyte precursors in tumours of adipose differentiation.
Joyner CJ; Triffitt J; Puddle B; Athanasou NA
Pathol Res Pract; 1999; 195(7):461-6. PubMed ID: 10448662
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical identification of tumours of adipocytic differentiation using an antibody to aP2 protein.
Bennett JH; Shousha S; Puddle B; Athanasou NA
J Clin Pathol; 1995 Oct; 48(10):950-4. PubMed ID: 8537497
[TBL] [Abstract][Full Text] [Related]
3. AP2 protein expression as a diagnostic marker in soft tissue tumours.
Yang TT; Reed AC; Athanasou NA
Sarcoma; 2001; 5(3):139-42. PubMed ID: 18521440
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of aP2/FABP4 expression in soft tissue tumours.
Kashima TG; Turley H; Dongre A; Pezzella F; Athanasou NA
Virchows Arch; 2013 Apr; 462(4):465-72. PubMed ID: 23511993
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic implications of Ki-67 expression in adipocytes and lipoblasts: an immunohistochemical study.
Wang HJ; Li CY; Wang YK
Int J Clin Exp Pathol; 2014; 7(12):8899-904. PubMed ID: 25674262
[TBL] [Abstract][Full Text] [Related]
6. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders.
Nuttall ME; Patton AJ; Olivera DL; Nadeau DP; Gowen M
J Bone Miner Res; 1998 Mar; 13(3):371-82. PubMed ID: 9525337
[TBL] [Abstract][Full Text] [Related]
7. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity.
Kopecky J; Clarke G; Enerbäck S; Spiegelman B; Kozak LP
J Clin Invest; 1995 Dec; 96(6):2914-23. PubMed ID: 8675663
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of leptin on brown and white adipose tissue.
Siegrist-Kaiser CA; Pauli V; Juge-Aubry CE; Boss O; Pernin A; Chin WW; Cusin I; Rohner-Jeanrenaud F; Burger AG; Zapf J; Meier CA
J Clin Invest; 1997 Dec; 100(11):2858-64. PubMed ID: 9389752
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels.
Coe NR; Simpson MA; Bernlohr DA
J Lipid Res; 1999 May; 40(5):967-72. PubMed ID: 10224167
[TBL] [Abstract][Full Text] [Related]
10. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of bone morphogenetic protein GDF-3/Vgr-2 expression in adipose tissue of FABP4/aP2 null mice.
Witthuhn BA; Bernlohr DA
Cytokine; 2001 May; 14(3):129-35. PubMed ID: 11396990
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE
Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470
[TBL] [Abstract][Full Text] [Related]
13. Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma.
Endo H; Hirokawa M; Ishimaru N; Tanaka Y; Yamashita M; Sakaki M; Hayashi Y; Sano T
Pathol Int; 2004 Mar; 54(3):145-50. PubMed ID: 14989736
[TBL] [Abstract][Full Text] [Related]
14. Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.
Scheja L; Makowski L; Uysal KT; Wiesbrock SM; Shimshek DR; Meyers DS; Morgan M; Parker RA; Hotamisligil GS
Diabetes; 1999 Oct; 48(10):1987-94. PubMed ID: 10512363
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues.
Shan T; Liu W; Kuang S
FASEB J; 2013 Jan; 27(1):277-87. PubMed ID: 23047894
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of adipocyte differentiation by HIV protease inhibitors.
Zhang B; MacNaul K; Szalkowski D; Li Z; Berger J; Moller DE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4274-7. PubMed ID: 10566684
[TBL] [Abstract][Full Text] [Related]
17. Distribution of basement membrane components in normal adipose tissue and in benign and malignant tumors of lipomatous origin.
Haraida S; Nerlich AG; Wiest I; Schleicher E; Löhrs U
Mod Pathol; 1996 Feb; 9(2):137-44. PubMed ID: 8657720
[TBL] [Abstract][Full Text] [Related]
18. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous.
Sen A; Lea-Currie YR; Sujkowska D; Franklin DM; Wilkison WO; Halvorsen YD; Gimble JM
J Cell Biochem; 2001 Mar; 81(2):312-9. PubMed ID: 11241671
[TBL] [Abstract][Full Text] [Related]
19. Regulation by fatty acids of angiotensinogen gene expression in preadipose cells.
Safonova I; Aubert J; Negrel R; Ailhaud G
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):235-9. PubMed ID: 9078267
[TBL] [Abstract][Full Text] [Related]
20. Caveolin expression is common among benign and malignant smooth muscle and adipocyte neoplasms.
Bayer-Garner I; Morgan M; Smoller BR
Mod Pathol; 2002 Jan; 15(1):1-5. PubMed ID: 11796834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
